1. TEAP
Progress Report 2011
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 1 1

2. Medical Technical Options Committee
TEAP
Medical Technical Options Committee
Essential Use Nominations and Progress Report
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 2 2

3. Essential Uses: Metered Dose Inhalers (1)
EUNs submitted by Bangladesh, China, Pakistan, Russian Federation
877 tonnes requested; 793 tonnes recommended for 2012
65% lower than 2011
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

4. Essential Uses: Metered Dose Inhalers (2)
CFCs for beta-agonist, and for inhaled corticosteroid
CFC MDIs nominated by China for export: Not Recommended
Affordable alternatives available for importing countries
Essentiality not demonstrated for importing countries
China already exports HFC MDIs
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

5. Essential Uses: Metered Dose Inhalers (3)
Anti-cholinergics: limited CFC-free range available but increasing
CFCs for anti-cholinergics:
Recommended for Bangladesh, Pakistan for 2012
Not Recommended for China – more than one alternative available, China’s phase-out strategy satisfied
Combinations capped at 2011 levels
CFCs for anti-cholinergics and their combinations not likely to qualify as essential beyond 2012.
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

6. Essential Uses: Metered Dose Inhalers (4)
Combination salmeterol/fluticasone:
CFCs nominated by Bangladesh for 2012: alternatives available by 2012; Not Recommended
Sodium cromoglycate: Alternatives available globally.
CFCs nominated by China for domestic use : criteria for non-essentiality of cromoglycate CFC MDIs may be already satisfied – MTOC requests confirmation. CFCs for sodium cromoglycate not likely to be considered essential beyond Recommended for 2012 only
CFCs nominated by China for export to Cuba: Cuba requested import; alternatives may not yet be approved by regulatory authorities in Cuba. Recommended for 2012 only
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

7. Essential Uses: Metered Dose Inhalers (5)
New CFC MDIs continue to be launched in A5s after 2010
Parties that continue to use CFC MDIs may consider:
Fast-track administrative processes (esp. China, Russia) to speed up transition to CFC-free alternatives
Domestic regulations to ban import/export of beta-agonists and inhaled corticosteroid CFC MDIs
Domestic pricing policies (pricing, import and drug approvals) to expedite transition to CFC-free inhalers with priority of protecting patient health
Consolidating MDI operations and ceasing nominations for manufacturers where there is no intention to reformulate (China)
Domestic regulations to ban the launch or sale of new CFC MDIs in A5s, even if already approved but not launched
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

8. Essential Uses: Summary for Metered Dose Inhalers
For Parties nominating in 2011: Authorized for 2011; Nominated (Recommended) 2012 and 2013 in metric tonnes
Party
2011
Authorized
2012
Nominated (recommended)
2013
Bangladesh
57.0
40.35 (24.67) -
China
741.15
(532.04)
Pakistan
39.6
24.1 (24.1)
Russian Fed.
212.0
250 (212.0)
125 (0.0)
Argentina did not make a nomination for CFCs for 2012.
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

9. Essential Uses MDIs: Bangladesh, Pakistan, Russia
Bangladesh will not nominate CFCs after 2012
Pakistan unlikely to nominate CFCs after 2012
The Russian Federation
The Russian Federation has faced many delays since the 1996 phase-out deadline for non-A5s, and now projects phase-out by the end of However, affordable imported alternatives are available
MTOC recommends the same quantity (212 tonnes) for Russian Federation as authorised in 2010 and 2011, and is unable to recommend CFCs for 2013
If manufacturing conversion not achieved by the end of 2012, patient demand may require the Russian Federation to increase importation of affordable salbutamol CFC-free inhalers
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

10. Essential Uses MDIs: China
China plans total phase-out by the end of 2016
Salbutamol CFC MDIs will remain essential until four different CFC-free MDIs from four different national enterprises are available
China’s registration process can take up to four years.
Only two applications for salbutamol HFC MDIs have been submitted (one marketed by 2012?). One imported salbutamol HFC MDI has 20% market share (price regulated at same maximum as local CFC MDIs).
Locally-made DPIs may also be available.
Together these would provide an adequate range of affordable alternatives for early and safe phase-out in China
China nomination includes many companies seeking small CFC quantities for products that may not be reformulated. Without future demonstrated R&D evidence in 2012, MTOC unlikely to recommend that portion of the nomination
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

11. Stockpiles
Pharmaceutical-grade CFC stocks are ~1,940 tonnes end of 2010
~1,000 tonnes of stocks remain in the EU, India, and US, which do not have authorised EUEs for 2011 or beyond
TEAP’s interpretation is that during final stages of CFC MDI phase-out, CFC stockpiles are utilised only in uses authorised through an EUE or otherwise appropriately destroyed
EU indicated that some EUE CFC stockpile has gone to process agent use
Parties may wish to consider whether EUE CFC stockpile use as process agent or feedstock is appropriate
Corrigendum published to correct global consumption and stockpile data in the Progress Report.
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

12. Chemicals Technical Options Committee
TEAP
Chemicals Technical Options Committee
Progress Report
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 12 12

13. Process Agents
Table A in decision XXII/8 contains 41 ODS uses registered as process agents
27 process agent uses discontinued and are recommended by TEAP and the CTOC to be removed from Table A.
14 process agent uses will remain in Table A.
Columbia reported to cease using CTC in the elimination of NCl3 in chlor-alkali production after 2011 (#1 in Table A).
Provision of data for Table B has improved with maximum emissions of 1,320 metric tonnes
As of 1 March 2011, 93 parties have notified that they have no process agent uses
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

14. Laboratory and Analytical Uses - ODS
Alternatives are available for most laboratory and analytical uses, but for very few CTC uses there are no alternatives
Many laboratories have been slow to adopt alternatives
Work with International Standards bodies in the search for new standard methods not using ODS continues
Parties may wish to require reporting of remaining ODS laboratory and analytical uses
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

15. Essential Use Exemptions
The CTOC recommends the Russian Federation’s request for 100 metric tonnes of CFC-113 solvent for manufacturing aerospace equipment in 2012, acknowledging expansion of their domestic space programme and unresolved problems with alternatives
The CTOC is unable to recommend Jordan’s request for use of bromochloromethane (BCM) as a solvent for polymeric fire retardants in a new production facility, because alternative solvents to BCM are available

16. Update of n-PB
Decision XIII/7(3) has requested the TEAP to report annually on n-PB uses and emissions
The CTOC reported repeatedly the difficulties of obtaining accurate data on production and uses of n-PB because n-PB is not a controlled substance under the Montreal Protocol, although it has been registered under the new EU REACH regulation
Parties may wish to reconsider the practicability of the Decision XIII/7

17. Emissions of CTC and other ODS
The large gap between top-down and bottom-up estimates of CTC emissions still remains unexplained
Scientists continue work on the estimation of the atmospheric lifetime of CTC
Estimates on feedstocks of ODS have been updated but uncertainties remain because of commercial confidentiality and no reporting requirement on uses or emissions

18. Destruction Technologies
The CTOC has reviewed emerging technologies submitted from SGL CARBON, LESNI, ASADA Corporation, Midwest Refrigerants, University of Newcastle, SRL Plasma and Nordiko Quarantine Systems
The results of its review were provided to the XXII/10 TEAP Task Force
Information on destruction projects in Article 5 Parties was provided by UNDP and brief reports have been included in the CTOC Progress Report
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

19. Halons Technical Options Committee
TEAP
Halons Technical Options Committee
Progress Report
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 19 19

20. HTOC Progress Report New halon alternatives / technologies
Twin fluid air/water system atomises water to ultra fine mist
Water & nitrogen systems provide dual fire extinguishing benefits
Water based agents using multiple salts achieve very low freezing point (-70oC) and film-forming capabilities
Pyrotechnic products that generate nitrogen and nitrogen/water
Phosphorus tribromide in small aircraft engine nacelles
Unsaturated HFCs and HBFC, and a fluoroketone are being tested
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 20 20

21. HTOC Progress Report
Halon 1301 still produced in China & France for feedstock
In India, halon that is recovered from ship breaking and industrial applications is often sold without proper purification and testing
In China, halons recovered from decommissioned equipment are now classified as a hazardous waste that cannot be re-used. The companies who were anticipated to collect and recycle halons do not have hazardous waste management licenses and have shown little interest in managing halons as a hazardous waste.
A new recycling standard for halon 1211 has been issued by ASTM International
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 21

22. Report of the XXII/22 Task Force
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 22 22

23. Decision XXII/22 - Membership of Task Force
Balanced task force of eight members
All TOCs represented
Two additional TEAP senior experts
Co-chairs
Marta Pizano MBTOC (and TEAP Co-chair) (A5)
Dan Verdonik HTOC (non-A5)
Members
Paul Ashford FTOC (non-A5)
Bella Maranion TEAP Senior Expert (non-A5)
Roberto Peixoto RTOC (A5)
Helen Tope MTOC (non-A5 )
Maasaki Yamabe CTOC (non-A5 )
Shiqiu Zhang TEAP Senior Expert (A5)

24. Mandate Decision XXII/22 requested the TEAP and its TOCs to
Draw up guidelines for nomination of experts by the Parties, in accordance with section 2.9 of the Terms of Reference
Consider need for balance and appropriate expertise when appointing members of TOCs, Task Forces and other subsidiary groups in accordance with sections 2.1, 2.5 and 2.8 of the Terms of Reference

25. Balance TF considered different criteria to define balance
Dec XXII/22 TF defines balance as:
Article 5 versus non-Article 5
Within that overall balance, regional distribution
TEAP strives for overall balance and expertise in appointing members

26. Appointments
TOC members are appointed by TOC Co-chairs in consultation with TEAP, per paragraph 2.5 of the TOR.
TOCs continually seek to:
Maintain and improve expertise and balance
Refresh TOC membership for upcoming Assessments
Recruit members through nominations by Parties, TOC members, associates, industry, professional and academic organizations, and others.
Parties, not TEAP, decide the appointments to TEAP
Therefore, did not address TEAP balance
Exceptions
Temporary TOC Co-chairs
TSB Co-chairs not already members of TEAP, who become temporary members of TEAP

27. Current and Required Capabilities
TF recognizes current matrix of expertise may not provide sufficient information
More information on the required expertise
Practical information about TEAP or TOC membership
User-friendly website / interface?
Standardise / improve matrices on current capabilities
Standard format
TEAP/TOC matrix of expertise, could be made into a searchable database
Significant changes / improvements would need help from Ozone Secretariat, which has the means and resources

28. Guidelines for Nominations
TEAP Members
TOR recommends approximately members with a goal of about 50% Article 5 members
Matrix of expertise to be updated in 2012 TEAP progress report
Co-Chairs of TOCs
TOR states that TOCs should have 2 or, if appropriate, 3 Co-chairs
TOC Members
TOR states that TOC Co-chairs appoint members in coordination with TEAP
Matrix of expertise to be updated bi-annually (January and July) beginning in 2012

29. Standard Nomination Information
Cover letter
Formal education and other qualifications
Employment / other relevant work experience
Past experience conducting similar or related work
English language proficiency in speaking and writing
Relevant professional references
Relevant publications
Additional qualifications that could aid selection process
Professional memberships and / or awards
The country and / or world region where the nominee is situated or has experience.
Source of funding or support for position

30. Summary If agreed by Parties,
Searchable database, TEAP/TOC Matrix of Expertise
More user-friendly web-based interface
Could be developed if resourced and managed by the Ozone Secretariat
TF recommends creating a standard nomination form containing required information or at least standardizing nomination content, which TOC co-Chairs would use for TOC appointments, and which TEAP would use in recommending TEAP appointment for Parties’ consideration and confirmation
Parties may wish to consider if TEAP should develop a standard nomination form

31. TEAP & TOC Operations
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l 31 31

32. Minority reports Minority Reports
There were 5 minority reports in the first 20 years of the TEAP operation
In 2011 there are 3 minority reports and a minority viewpoint
3 minority reports regarding methyl bromide critical use exemptions
1 minority viewpoint regarding methyl formate foam blowing agent
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

33. Enhancing MBTOC Consensus Process
TEAP asked the MBTOC, where possible, to organize its meeting agendas in the future to allow members of each subcommittee to attend discussions on each topic necessary to contribute to an informed decision and to consider other strategies to support achieving consensus on methyl bromide Critical Use Exemptions (CUEs) and other important topics
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

34. TEAP Notes New Nominations
The Government of Japan has nominated Masaaki Yamabe to move from the position of Co-Chair of the Chemicals Technical Options Committee (CTOC) to the position of TEAP Senior Expert Member, and
The Government of Japan nominated CTOC member Keiichi Ohnishi to the position of Co-Chair of the CTOC
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

35. Disclosure of Interest
TEAP instructed members to redouble efforts to update and assure completeness of disclosures of interest for all TEAP, TOCs and TSB members and requested the Ozone Secretariat to improve the UNEP Ozone Secretariat Website to track the dates of updated postings
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l

36. TEAP Guidelines on Recusal
TEAP defines recusal as: “to disqualify from specific participation for good reason”
The purpose of recusal is to avoid appearance or consequence of a conflict of interest when an interested party would have good reason to question the objectivity and fairness of involvement of a TEAP/TOC/TSB member in specific actions such as CUNs and EUEs
TEAP guidelines cover self-recusal and recusal by TEAP Co-Chairs and by TOC Co-Chairs
M o n t r e a l P r o t o c o l O E W G m e e t i n g, A u g u s t , M o n t r e a l